Welltower (WELL) Q2 2026 Earnings
How Did WELL Stock React to Q2 2026 Earnings?
S&P 500 over the same 30 days: +4.08%.
Did WELL Beat Earnings? Q2 2026 Results
Yes. Welltower reported Q2 2026 earnings of $1.60 a share on Jul 27, 2026, beating the $0.65 consensus estimate by 146.2%. Revenue was $3.5B against a $3.4B estimate.
Welltower delivered a standout second quarter for 2026, posting normalized FFO of $1.60 per diluted share against a consensus estimate of $0.65, a beat of 146.15% that reflected the sweeping scale of the company's recent expansion. Revenue reached $3.54 billion, up 40.9% year-over-year and ahead of the $3.39 billion analysts had expected, with the Seniors Housing Operating segment serving as the primary engine, generating $3.00 billion in consolidated SHO revenues alone. The April 1 closing of the Amica Senior Lifestyles acquisition, encompassing 38 Canadian senior housing communities at a pro rata purchase price of C$4.10 billion, was the single largest contributor to that revenue surge, compounding organic momentum that included 20.5% SHO same-store NOI growth and average occupancy climbing to 89.4% from 86.1% a year ago. With institutional ownership near 95% and analyst sentiment broadly constructive, investor confidence appears well-anchored. Management raised full-year 2026 normalized FFO guidance to $6.36-$6.44 per diluted share and lifted the quarterly dividend 15% to $0.85 per share.
- SHO same store NOI growth of 20.5% year-over-year
- 330 basis points of average occupancy growth in SHO portfolio
- 5.2% growth in Revenue Per Occupied Room (RevPOR)
- SHO same store occupancy reached 89.4%, up from 86.1% a year ago
- Total portfolio SSNOI growth of 15.5%
- 93.0% private pay revenue mix in Seniors Housing Operating
- Seniors Housing Triple-net SSNOI growth of 5.2%
- Long-Term/Post-Acute Care SSNOI growth of 2.9%
- Outpatient Medical SSNOI growth of 2.4%
- U.S. SHO SS RevPOR YoY growth of 5.3%, U.K. 3.9%, Canada 6.1%
What Is Welltower's Outlook?
Welltower raised its full-year 2026 normalized FFO guidance to $6.36–$6.44 per diluted share from the prior range of $6.21–$6.35. GAAP net income guidance was revised to $3.11–$3.19 per diluted share from $3.24–$3.38. Blended SSNOI growth is expected at 13.75%–16.00%, with SHO approximately 18.5%–21.5%, Seniors Housing Triple-net approximately 3.5%–4.5%, Outpatient Medical approximately 2.0%–3.0%, and Long-Term/Post-Acute Care approximately 2.0%–3.0%. G&A expenses are anticipated at approximately $265–$270 million with stock-based compensation of approximately $60 million. Pro rata disposition proceeds of $1.1 billion are expected at a blended yield of 6.8% over the next twelve months. Guidance includes only announced or closed acquisitions and no additional capital transactions.
WELL YoY Financials
| Metric | Q2 2026 | Q2 2025 | Year over year |
|---|---|---|---|
| Revenue | $3.5B | $2.5B | +40.9% |
| Operating Income | $320.4M | $443.3M | −27.7% |
| Net Income | $463.0M | $301.9M | +53.4% |
WELL Revenue by Segment
WELL Revenue by Geography
When Does Welltower Report Next?
Figures from SEC filings and company reports. Not investment advice.